Valence8 US LP
- SEC CIK
- 0001943819
- 最新申報
- 2026/8/6
2024 年第 3 季持倉
持倉截至 2024/9/30，2024/11/12 申報。只含多頭部位，變化是跟 2024 年第 2 季比股數。
- 持股檔數
- 40
- 較 2024 年第 2 季 +31
- 總值
- $2.29 億
- 較 2024 年第 2 季 +$3,757 萬 (+19.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| iShares MSCI USA Quality Factor ETF46432F339 | ETF | 337,472 | $6,051 萬 | 26.4% | +36,424+12.1% | 加碼 | – |
| Invesco QQQ Trust Series I46090E103 | ETF | 88,149 | $4,302 萬 | 18.8% | +11,438+14.9% | 加碼 | – |
| iShares Tr46434V456 | MSCI INTL QUALTY | 1,026,290 | $4,258 萬 | 18.6% | +134,097+15.0% | 加碼 | – |
| iShares Tr464288877 | EAFE VALUE ETF | 399,186 | $2,297 萬 | 10.0% | 00.0% | 不變 | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 96,630 | $1,687 萬 | 7.4% | −3,373−3.4% | 減碼 | – |
| State Street Consumer Staples Select Sector SPDR ETF81369Y308 | ETF | 165,267 | $1,372 萬 | 6.0% | −3,033−1.8% | 減碼 | – |
| iShares Tr46435G334 | MSCI UK ETF NEW | 209,344 | $783.2 萬 | 3.4% | −7,590−3.5% | 減碼 | – |
| iShares Inc46434G822 | MSCI JAPAN ETF | 108,634 | $777.2 萬 | 3.4% | 00.0% | 不變 | – |
| State Street Utilities Select Sector SPDR ETF81369Y886 | ETF | 51,940 | $419.6 萬 | 1.8% | −3,648−6.6% | 減碼 | – |
| JAZZJazz Pharmaceuticals plc | SHS USD | 8,969 | $99.9 萬 | 0.4% | +8,969 | 新進 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 17,785 | $92.0 萬 | 0.4% | +17,785 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 4,585 | $68.5 萬 | 0.3% | +4,585 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 7,865 | $57.4 萬 | 0.3% | +7,865 | 新進 | 歷史 |
| INDVIndivior Pharmaceuticals, Inc. | ORD | 57,293 | $56.4 萬 | 0.2% | +57,293 | 新進 | 歷史 |
| LLYEli Lilly & Co | Stock | 633 | $56.1 萬 | 0.2% | +633 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 953 | $51.7 萬 | 0.2% | +953 | 新進 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 9,706 | $49.0 萬 | 0.2% | +9,706 | 新進 | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 8,025 | $46.6 萬 | 0.2% | +8,025 | 新進 | 歷史 |
| NUVLNuvalent, Inc. | COM | 4,115 | $42.1 萬 | 0.2% | +4,115 | 新進 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 7,857 | $35.7 萬 | 0.2% | +7,857 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 6,684 | $34.2 萬 | 0.1% | +6,684 | 新進 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 13,188 | $31.0 萬 | 0.1% | +13,188 | 新進 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 5,240 | $30.8 萬 | 0.1% | +5,240 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 2,468 | $28.2 萬 | 0.1% | +2,468 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 13,020 | $26.8 萬 | 0.1% | +13,020 | 新進 | 歷史 |
| VIRVir Biotechnology, Inc. | COM | 33,650 | $25.2 萬 | 0.1% | +33,650 | 新進 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 2,618 | $24.2 萬 | 0.1% | +2,618 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,241 | $23.6 萬 | 0.1% | +4,241 | 新進 | 歷史 |
| ENTAEnanta Pharmaceuticals Inc | COM | 19,939 | $20.7 萬 | 0.1% | +19,939 | 新進 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 26,200 | $18.5 萬 | 0.1% | +26,200 | 新進 | 歷史 |
| ZVRAZevra Therapeutics, Inc. | COM NEW | 21,596 | $15.0 萬 | 0.1% | +21,596 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 46,923 | $12.8 萬 | 0.1% | +46,923 | 新進 | 歷史 |
| SLDBSolid Biosciences Inc. | COM NEW | 15,728 | $11.0 萬 | <0.1% | +15,728 | 新進 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 34,376 | $10.3 萬 | <0.1% | +34,376 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 17,495 | $7.10 萬 | <0.1% | +17,495 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 14,708 | $6.85 萬 | <0.1% | +14,708 | 新進 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 12,045 | $6.13 萬 | <0.1% | +12,045 | 新進 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM NEW | 18,511 | $4.76 萬 | <0.1% | +18,511 | 新進 | 歷史 |
| NKTRNektar Therapeutics | COM | 26,107 | $3.39 萬 | <0.1% | +26,107 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 21,136 | $1.63 萬 | <0.1% | +21,136 | 新進 | 歷史 |
選擇權（20 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | – | $498.6 萬 |
| AMGNAmgen Inc | Stock | $64.4 萬 | $64.4 萬 |
| SLNOSoleno Therapeutics Inc | COM | – | $63.1 萬 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $61.5 萬 |
| INSMINSMED Inc | COM PAR $.01 | – | $48.2 萬 |
| NVONovo Nordisk A S | ADR | – | $46.4 萬 |
| FLNAFilana Therapeutics, Inc. | COM | $41.5 萬 | – |
| RAREUltragenyx Pharmaceutical Inc. | COM | – | $38.3 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $37.8 萬 |
| AVDLAvadel Pharmaceuticals PLC | Stock | – | $34.4 萬 |
| ALTAltimmune, Inc. | COM NEW | $14.4 萬 | $16.1 萬 |
| VRDNViridian Therapeutics, Inc. | COM | – | $29.8 萬 |
| MRNAModerna, Inc. | Stock | – | $27.4 萬 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | $22.1 萬 | – |
| APLTApplied Therapeutics, Inc. | COM | – | $17.3 萬 |
| IOVAIovance Biotherapeutics, Inc. | COM | – | $12.3 萬 |
| JANXJanux Therapeutics, Inc. | COM | $10.4 萬 | – |
| BCRXBiocryst Pharmaceuticals Inc | COM | – | $9.96 萬 |
| CCCCC4 Therapeutics, Inc. | COM STK | – | $5.99 萬 |
| GOSSGossamer Bio, Inc. | COM | – | $2.04 萬 |